Skip to main content
H.R. 3248 118th Congress House

Diagnostic Lab Testing Transparency Act

Official title: To amend title XVIII of the Social Security Act to increase price transparency of clinical diagnostic laboratory tests under the Medicare program.

Introduced: May 11, 2023 Introduced by: Mariannette Miller-Meeks Republican · Iowa See on congress.gov
Health Civil actions and liabilityHealth care costs and insuranceMedical tests and diagnostic methods
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 17, 2024
Referred to the Subcommittee on Health.
May 12, 2023
Referred to the Subcommittee on Health.
May 11, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 11, 2023
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action December 17, 2024

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Diagnostic Lab Testing Transparency Act

This bill requires providers of clinical diagnostic laboratory tests under Medicare to publicly post certain information relating to the prices of services.

Specifically, providers must post and annually update information about the discounted cash price and the minimum and maximum negotiated rates of each test, including ancillary services. The Centers for Medicare & Medicaid Services may assess civil penalties for violations.

 Related & companion bills 1
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Lobbying activity 4

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

Bodies those filers lobbied

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

 Cosponsors 1
All 1 Democratic 1
D
DeGette, Diana
Colorado · May 11, 2023
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 3248: Diagnostic Lab Testing Transparency Act. 118th Congress. Open America. https://openamerica.io/bill/118-HR-3248/
MLA
"H.R. 3248: Diagnostic Lab Testing Transparency Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-3248/.
Bluebook (legal)
H.R. 3248, 118th Cong. (2026), https://openamerica.io/bill/118-HR-3248/.
Markdown link
[H.R. 3248: Diagnostic Lab Testing Transparency Act](https://openamerica.io/bill/118-HR-3248/)
Report a problem